Thromboembolic Events Related to Treatment with Checkpoint Inhibitors: Report of Two Cases

Despite the significant clinical benefits, checkpoint inhibition is associated with a unique spectrum of immune-related adverse events. It is sometimes difficult to distinguish some rare adverse effects from a cancer progression; thus, such effects should be reported in clinical trials to be diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukamoto, Jessica, Monteiro, Mariana, Vale, Silvana, Lemos, Cynthia, Scarpelli, Thais, Carvalho, Leticia, Pezzutti, Daniela, Brandão, Raphael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243904/
https://www.ncbi.nlm.nih.gov/pubmed/30483092
http://dx.doi.org/10.1159/000492463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243904/
https://www.ncbi.nlm.nih.gov/pubmed/30483092
http://dx.doi.org/10.1159/000492463

Ejemplares similares